Compare TOST & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOST | ZBH |
|---|---|---|
| Founded | 2012 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 16.0B |
| IPO Year | 2021 | 2001 |
| Metric | TOST | ZBH |
|---|---|---|
| Price | $24.53 | $87.96 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 22 | 21 |
| Target Price | $41.29 | ★ $101.00 |
| AVG Volume (30 Days) | ★ 11.4M | 1.9M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.20% |
| EPS Growth | ★ 1766.67 | N/A |
| EPS | 0.20 | ★ 1.22 |
| Revenue | $6,153,000,000.00 | ★ $8,231,500,000.00 |
| Revenue This Year | $22.69 | $4.96 |
| Revenue Next Year | $18.03 | $3.76 |
| P/E Ratio | $121.50 | ★ $72.27 |
| Revenue Growth | ★ 24.05 | 7.20 |
| 52 Week Low | $22.26 | $79.12 |
| 52 Week High | $49.66 | $108.29 |
| Indicator | TOST | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 46.40 | 56.82 |
| Support Level | $22.26 | $85.38 |
| Resistance Level | $30.36 | $102.52 |
| Average True Range (ATR) | 0.97 | 2.19 |
| MACD | 0.09 | 0.73 |
| Stochastic Oscillator | 29.39 | 70.36 |
Toast Inc is a cloud-based, all-in-one digital technology platform purpose-built for the restaurant community. The company provides a comprehensive platform of software-as-a-service (SaaS) products and financial technology solutions, including integrated payment processing, restaurant-grade hardware, and a broad ecosystem of third-party partners. It serves as a restaurant operating system, connecting front of house and back of house operations across service models such as dine-in, takeout, and delivery. It operates through one reportable segment consisting of its SaaS products, financial technology solutions, integrated payments, hardware, and partner ecosystem.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.